0000899243-18-006553.txt : 20180306
0000899243-18-006553.hdr.sgml : 20180306
20180306202916
ACCESSION NUMBER: 0000899243-18-006553
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180302
FILED AS OF DATE: 20180306
DATE AS OF CHANGE: 20180306
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Mauro Anthony
CENTRAL INDEX KEY: 0001534275
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 333-199861
FILM NUMBER: 18671672
MAIL ADDRESS:
STREET 1: 1500 CORPORATE DRIVE
CITY: CANONSBURG
STATE: PA
ZIP: 15317
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Mylan N.V.
CENTRAL INDEX KEY: 0001623613
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 981189497
STATE OF INCORPORATION: P7
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: BUILDING 4, TRIDENT PLACE, MOSQUITO WAY
CITY: HATFIELD, HERTFORDSHIRE
STATE: X0
ZIP: AL10 9UL
BUSINESS PHONE: 44 0 1707 853 000
MAIL ADDRESS:
STREET 1: BUILDING 4, TRIDENT PLACE, MOSQUITO WAY
CITY: HATFIELD, HERTFORDSHIRE
STATE: X0
ZIP: AL10 9UL
FORMER COMPANY:
FORMER CONFORMED NAME: New Moon B.V.
DATE OF NAME CHANGE: 20141028
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-03-02
0
0001623613
Mylan N.V.
MYL
0001534275
Mauro Anthony
BUILDING 4, TRIDENT PLACE, MOSQUITO WAY
HATFIELD, HERTFORDSHIRE
X0
AL10 9UL
UNITED KINGDOM
0
1
0
0
Chief Commercial Officer
Ordinary Shares
2018-03-02
4
M
0
4757
22.66
A
147435
D
Ordinary Shares
2018-03-02
4
S
0
12257
40.35
D
135178
D
Ordinary Shares
2018-03-03
4
M
0
5534
0.00
A
140712
D
Ordinary Shares
2018-03-03
4
F
0
2310
40.97
D
138402
D
Ordinary Shares
2018-03-04
4
M
0
2056
0.00
A
140458
D
Ordinary Shares
2018-03-04
4
F
0
895
40.97
D
139563
D
Ordinary Shares
2018-03-04
4
M
0
13880
0.00
A
153443
D
Ordinary Shares
2018-03-04
4
F
0
5759
40.97
D
147684
D
Ordinary Shares
5574
I
By 401(k) Plan
Employee Stock Option - Right to Buy
22.66
2018-03-02
4
M
0
4757
0.00
D
2021-03-02
Ordinary Shares
4757
0
D
Employee Stock Option - Right to Buy
40.97
2018-03-02
4
A
0
29833
0.00
A
2028-03-02
Ordinary Shares
29833
29833
D
Restricted Stock Units
0.00
2018-03-02
4
A
0
18307
0.00
A
Ordinary Shares
18307
18307
D
Restricted Stock Units
0.00
2018-03-03
4
M
0
5534
0.00
D
Ordinary Shares
5534
11067
D
Restricted Stock Units
0.00
2018-03-04
4
M
0
2056
0.00
D
Ordinary Shares
2056
0
D
Performance Restricted Stock Units
0.00
2018-03-04
4
M
0
13880
0.00
D
Ordinary Shares
13880
0
D
Represents the acquisition of Mylan ordinary shares upon exercise of stock options granted on March 2, 2011.
Represents withholding of ordinary shares for the tax liability associated with the vesting and settlement of a portion of the restricted stock units (RSUs) granted on March 3, 2017.
Represents withholding of ordinary shares for the tax liability associated with the vesting and settlement of a portion of the RSUs granted on November 17, 2015.
Represents withholding of ordinary shares for the tax liability associated with the vesting and settlement of the performance restricted stock units (PRSUs) granted on November 17, 2015.
The grant, of which these options were a part, vested in three equal installments beginning on March 2, 2012.
9,945 of the options will vest on March 2, 2019, and 9,944 of the options will vest on each of March 2, 2020 and March 2, 2021. The options expire on March 2, 2028.
Each RSU represents the right to receive one ordinary share of Mylan N.V. 6,103 of the RSUs will vest on March 2, 2019, and 6,102 will vest on each of March 2, 2020 and March 2, 2021.
Each RSU represents the right to receive one ordinary share of Mylan N.V. 5,534 of the RSUs granted on March 3, 2017 vested on March 3, 2018, 5,534 will vest on March 3, 2019, and 5,533 will vest March 3, 2020.
Each RSU represents the right to receive one ordinary share of Mylan N.V. 2,057 of the RSUs granted on November 17, 2015 vested on March 4, 2016, and 2,056 vested on each of March 4, 2017 and March 4, 2018.
Each PRSU represents the right to receive one ordinary share of Mylan N.V. The PRSUs were initially granted on November 17, 2015, subject to the attainment of previously established two-year performance goals and a vesting period. The PRSUs fully vested on March 4, 2018.
/s/ Kevin Macikowski, by power of attorney
2018-03-06